Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
KRAS G12C INHIBITORS ENCOMPASSING A PIPERAZINE RING AND USE THEREOF IN THE TREATMENT OF CANCER
Document Type and Number:
WIPO Patent Application WO/2020/050890
Kind Code:
A3
Abstract:
Provided herein are KRAS G12C inhibitors, such as [Insert Compound Here] composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.

Inventors:
ALLEN JOHN GORDON (US)
LANMAN BRIAN ALAN (US)
CHEN JIAN (US)
REED ANTHONY B (US)
CEE VICTOR J (US)
LIU LONGBIN (US)
LOPEZ PATRICIA (US)
WURZ RYAN PAUL (US)
NGUYEN THOMAS T (US)
BOOKER SHON (US)
ALLEN JENNIFER REBECCA (US)
CHU-MOYER MARGARET (US)
AMEGADZIE ALBERT (US)
CHEN NING (US)
GOODMAN CLIFFORD (US)
LOW JONATHAN D (US)
MA VU VAN (US)
MINATTI ANA ELENA (US)
NISHIMURA NOBUKO (US)
PICKRELL ALEXANDER J (US)
WANG HUI-LING (US)
SHIN YOUNGSOOK (US)
SIEGMUND AARON C (US)
YANG KEVIN C (US)
TAMAYO NURIA A (US)
WALTON MARY (US)
XUE QIUFEN (US)
Application Number:
PCT/US2019/036626
Publication Date:
June 25, 2020
Filing Date:
June 11, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AMGEN INC (US)
International Classes:
C07D471/04; A61K31/519; A61K31/551; A61K45/06; A61P35/00; C07D487/04
Domestic Patent References:
WO2015054572A12015-04-16
WO2017201161A12017-11-23
WO2019051291A12019-03-14
WO2018217651A12018-11-29
WO2019213516A12019-11-07
WO2019241157A12019-12-19
Other References:
KM MORRISSEY ET AL: "Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities : Immunotherapy and Novel Combinations in Oncology", CLINICAL AND TRANSLATIONAL SCIENCE - CTS, vol. 9, no. 2, 30 March 2016 (2016-03-30), US, pages 89 - 104, XP055415286, ISSN: 1752-8054, DOI: 10.1111/cts.12391
Attorney, Agent or Firm:
REIDY, Joseph F. (US)
Download PDF: